Company

Infensa Bioscience

Biotechnology Research Brisbane, Queensland, Au 15 employees

Employees: 15
Contacts: 3
Emails: 3
Phones: 2

www.infensabioscience.com LinkedIn

Infensa Bioscience Overview

Headquarters: Brisbane, Queensland, Au
Website: www.infensabioscience.com
Industry: Biotechnology Research
Employees: 15
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Pharmaceutical molecules peptide hi1a research heart attack stroke ischemic start up blood brain venom

About Infensa Bioscience

First-in-class drugs with addressable worldwide market of tens of millions of patients per year who suffer heart attack or stroke. Ability of a single drug class to address multiple diseases enables staged clinical development with continuous value creation. Other potential indications: traumatic head injury, hypoxic brain injury (cerebral palsy), retinal artery thrombosis, kidney artery thrombosis, cardiac and brain surgery, endarterectomy and heart valve replacement. Key asset protected by patents granted globally.

Infensa Bioscience Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Infensa Bioscience Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michael Ankersen Phd Mba	Senior Pharmaceutical Executive		View
Ananth Siva		Sydney, New South Wales, Australia	Email Phone
Mark Smythe	Chief Executive Officer	Greater Brisbane Area, Australia	Email Phone
Alan Robertson	Managing Director at Canthera Discovery	Greater Sydney Area, Australia	Email